This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a significant role in the development of drugs targeting neurological disorders, particularly those involving nicotinic acetylcholine receptors. Its structure allows for further chemical modifications, making it valuable in creating compounds with potential therapeutic effects. Additionally, it is employed in research settings to study the biochemical pathways and mechanisms related to these receptors, aiding in the discovery of new treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other cognitive impairments.